雜志介紹

Anaesthesia雜志介紹

《Anaesthesia》是一本(ben)(ben)以(yi)English為主(zhu)(zhu)的(de)(de)(de)未開放獲(huo)取國際優(you)秀(xiu)期刊(kan)，中文名稱麻醉，本(ben)(ben)刊(kan)主(zhu)(zhu)要出版、報道醫學(xue)-ANESTHESIOLOGY領(ling)(ling)域的(de)(de)(de)研(yan)究動(dong)態以(yi)及(ji)在該領(ling)(ling)域取得的(de)(de)(de)各方面的(de)(de)(de)經(jing)驗(yan)和科(ke)研(yan)成果(guo)，介紹該領(ling)(ling)域有關本(ben)(ben)專業的(de)(de)(de)最(zui)新進展，探討行(xing)業發(fa)展的(de)(de)(de)思(si)路和方法，以(yi)促進學(xue)術信息(xi)交流，提高行(xing)業發(fa)展。該刊(kan)已被國際權威數據庫SCIE收錄，為該領(ling)(ling)域相關學(xue)科(ke)的(de)(de)(de)發(fa)展起到了良好的(de)(de)(de)推(tui)動(dong)作用，也(ye)得到了本(ben)(ben)專業人員的(de)(de)(de)廣(guang)泛認可。該刊(kan)最(zui)新影響(xiang)因子為7.5，最(zui)新CiteScore 指數為21.2。

本刊近期中國學者發表的論(lun)文(wen)主(zhu)要有：

• Machine learning to predict myocardial injury and death after non-cardiac surgery

  Author: Nolde, J. M.; Schlaich, M. P.; Sessler, D. I.; Mian, A.; Corcoran, T. B.; Chow, C. K.; Chan, M. T. V.; Borges, F. K.; McGillion, M. H.; Myles, P. S.; Mills, N. L.; Devereaux, P. J.; Hillis, G. S.

• Alternatives to remifentanil for the analgesic component of total intravenous anaesthesia: a narrative review

  Author: Hughes, L. M.; Irwin, M. G.; Nestor, C. C.

• A randomised controlled trial of the non-inferiority of erector spinae plane block vs. thoracic paravertebral block for laparoscopic nephro-ureterectomy

  Author: Xu, Z. -z.; Li, X.; Chen, B. -l.; Yang, K. -l.; Wang, J.; Li, X. -y.; Zhang, H.; Wang, D. -x.

• A randomised controlled trial of dexmedetomidine for delirium in adults undergoing heart valve surgery

  Author: Wang, H. -B.; Jia, Y.; Zhang, C. -B.; Zhang, L.; Li, Y. -N.; Ding, J.; Wu, X.; Zhang, Z.; Wang, J. -H.; Wang, Y.; Yan, F. -X.; Yuan, S.; Sessler, D. I.

英文介紹

Anaesthesia雜志英文介紹

Anaesthesia is the official journal of the Association of Anaesthetists and is international in scope and comprehensive in coverage. It publishes original, peer-reviewed articles on all aspects of general and regional anaesthesia, intensive care and pain therapy, including research on equipment. Although primarily a clinical journal, we welcome submissions or basic science papers if the authors can demonstrate their clinical relevance. The median time from submission to first decision is 12 days. Article commenting is available on each individual paper allowing rapid responses to, and debate on, all published material.